Nike said Thursday (June 26) that the new U.S. tariffs currently in place will cost the company about $1 billion. [contact-form-7] The footwear and apparel company is working to mitigate that gross incremental price increase, Nike President and CEO Elliott Hill said in remarks prepared for delivery Thursday during the firm's fourth-quarter earnings call.

Meta bolstered its already considerable renewable power portfolio this week with string of deals that added over 1 gigawatt of generating capacity.

U.S. equities jumped at midday, with the S&P 500 and Nasdaq trading at record highs, as the U.S. struck a trade deal with China and indicated more agreements are coming. The Dow Jones Industrial Average was up as well.

LNN posts a Q3 earnings and revenue beat, fueled by a 60% surge in international irrigation sales and strong project wins.

Pfizer's Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with inhibitors.

F's Model e bets big on EVs, but it's the profitable Ford Blue unit that's powering the transition behind the scenes.

DKS drives growth through digital transformation, with GameChanger and Dick's Media Network at the core.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming August 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ROCKET INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CL.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming August 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR 3D SYSTEMS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIM.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CTO REALTY GROWTH, INC. (CTO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On June.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 22, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR HIMS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO.

LOS ANGELES, June 27, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ORGANON INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

Shareholders with losses of $100,000 or more are encouraged to contact the firm. BENSALEM, Pa.

LOS ANGELES, June 27, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Red Cat Holdings, Inc. (“Red Cat” or the “Company”) (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”).

LOS ANGELES , June 27, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ: FTRE) have opportunity to lead the securities fraud class action lawsuit.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Reddit, Inc. (“Reddit” or the “Company”) (NYSE: RDDT) securities between October 29, 2024 and May 20, 2025, inclusive (the “Class Period”). Reddit investors have until August 18, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN REDDIT, INC. (RDDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN T.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming August 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR TEMPUS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER.

Opening Bid anchor Brian Sozzi discusses what's driving markets for June 27, 2025. The S&P 500 and Nasdaq opened at record highs.

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2025.

WD-40 is a best-in-class operator with exceptional capital efficiency, brand power, and global distribution—but trades at a historically rich valuation. Despite strong fundamentals and consistent margin performance, free cash flow yield and dividend yield remain well below sector averages. I rate the stock a Hold due to its premium valuation; a re-rating could offer a more balanced risk/reward for long-term investors.